Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.11.2021 | Case report

Bendamustine/remdesivir/rituximab

Emergence of drug resistance and SARS-CoV-2 viraemia due to B-cell immunodeficiency : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Martinot M, et al. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clinical Infectious Diseases 73: e1762-e1765, No. 7, 1 Oct 2021. Available from: URL: http://doi.org/10.1093/cid/ciaa1474 Martinot M, et al. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clinical Infectious Diseases 73: e1762-e1765, No. 7, 1 Oct 2021. Available from: URL: http://​doi.​org/​10.​1093/​cid/​ciaa1474
Metadaten
Titel
Bendamustine/remdesivir/rituximab
Emergence of drug resistance and SARS-CoV-2 viraemia due to B-cell immunodeficiency : case report
Publikationsdatum
01.11.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-04923-3

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Multiple drugs

Case report

Agomelatine

Case report

Antineoplastics

Case report

Allopurinol